MUSCLE RELAXANTS. Mr. D.Raju, M.pharm, Lecturer

Similar documents
NERVOUS SYSTEM NERVOUS SYSTEM. Somatic nervous system. Brain Spinal Cord Autonomic nervous system. Sympathetic nervous system

Benztropine and trihexyphenidyl: Centrally acting antimuscarinic agents used for treatment of Parkinson disease & extrapyramidal symptoms.

NEUROMUSCULAR BLOCKING AGENTS

Chapter 18. Skeletal Muscle Relaxants (Neuromuscular Blocking Agents)

Pharmacology of the Neuromuscular Junction (NMJ)

Neuromuscular Blockers

Pharmacology of the Neuromuscular Junction (NMJ)

Ganglion blocking agents

(PP XI) Dr. Samir Matloob

Neuromuscular Junction

Chapter 18 Neuromuscular Blocking Agents Study Guide and Application Exercise

Cholinergic antagonists

The Latest Approaches to Reversal of Neuromuscular Blocking Agents

Nervous System. Peripheral Nervous System ( PNS ) Central Nervous System ( CNS ) Somatic. Autonomic ( ANS ) Enteric.

Skeletal Muscle Relaxants. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan March, 2014

BIMM118. Autonomic Nervous System

LESSON ASSIGNMENT. LESSON OBJECTIVES 3-1. Given a group of definitions, select the definition of the term muscle relaxant.

Pharmacology of neuromuscular blocking drugs

Skeletal Muscle Relaxants

Pharmacological Inhibition of skeletal muscle activity

Ganglionic Blocking Agents

Anesthesia and Neuromuscular Blockade: A Guide for Hospital Pharmacists. Upon completion of this activity, participants will be better able to:

Joseph F. Answine, MD

Cholinergic receptors( cholinoceptors ) are two families muscarinic and nicotinic depending on their affinities to cholinomimetic agents(agents that

Drugs Affecting the Autonomic Nervous System-2 Cholinergic agents

BIOP211 Pharmacology Tutorial Session 10 Drugs affecting the PNS

CHAPTER 11. General and Local Anesthetics. Anesthetics. Anesthesia. Eliza Rivera-Mitu, RN, MSN NDEG 26 A

Has little therapeutic value. Has multiple actions. Has short t ½ Activates muscarinic & nicotinic receptors. 10/17/2017 2

Suxamethonium Chloride Injection BP PRODUCT INFORMATION

Parasympathetic Nervous System Part I

ANTICHOLINERGIC DRUGS

A Successful RSI Program

number Done by Corrected by Doctor Malik

Pharmacology Autonomic Nervous System Lecture10

NEW ZEALAND DATA SHEET

Core Safety Profile. Pharmaceutical form(s)/strength: Solution for Injection CZ/H/PSUR/0005/002 Date of FAR:

Quelicin TM SUCCINYLCHOLINE CHLORIDE INJECTION, USP

Succinycholine: Succinylcholine has no place in pediatric anesthesia. Wads Ames MBBS FRCA

NEW ZEALAND DATA SHEET. Injection solution 2.5 mg/ml: a clear, colourless, particle-free solution containing 2.5 mg/ml Neostigmine methylsulphate.

Chapter 13. Learning Objectives. Learning Objectives 9/11/2012. Poisonings, Overdoses, and Intoxications

Effect of Vecuronium in different age group

PRESCRIBING INFORMATION QUELICIN. Neuromuscular Blocking Agent

Disclosure Statement:

Skeletal muscle relaxants

ANESTHESIA DRUG REVIEW

PRODUCT MONOGRAPH. Edrophonium Chloride Injection, USP. 10 mg/ml. Nondepolarizing Neuromuscular Antagonist

Ganglionic Blockers. Ganglion- blocking agents competitively block the action of

Autonomic Pharmacology: Cholinergic agonists

RMP section VI.2 Elements for Public Summary

Pain: 1-2µg/kg q30-60min prn. effects in 10 minutes. Contraindications: Morphine is preferred in. Duration of Action: minutes. renal failure.

PRODUCT INFORMATION. TRACRIUM INJECTION atracurium besylate DESCRIPTION:

Interface Prescribing Subgroup DRUGS FOR DEMENTIA: INFORMATION FOR PRIMARY CARE

SUMMARY OF PRODUCT CHARACTERISTICS

TRACRIUM GlaxoSmithKline

NEW ZEALAND DATA SHEET. Injection 2 mg/ml: a clear, colourless, particle-free solution containing 2 mg/ml pancuronium bromide.

The Neuromuscular Junction: Pharmacologic Applications During Anesthesia

Neuromuscular Blockers

Suggamadex. Suggamadex. Suggamadex 4/28/2015. Goals: By the End of this Lecture, the Participant should be able to:

What is MH? Malignant Hyperthermia (MH)! Malignant Hyperthermia (MH) Malignant Hyperthermia (MH) ! The underlying physical mechanismintracellular

PROSTIGMIN (neostigmine bromide)

Nervous System Divisions

Integrated Cardiopulmonary Pharmacology Third Edition

TRANSPARENCY COMMITTEE OPINION. 21 January 2009

Lecture 5 Skeletal muscle relaxants. Pharmacologic management of parkinsonism and other movement disorders.

Pharmacology Second. - Contraction of detrusor muscle in the bladder.

MESTINON NAME OF THE MEDICINE. Description: Pharmacology: Pyridostigmine Bromide. CAS number:

FOR REPRESENTATIVE EDUCATION

08-15 NORCURON ORGANON

Laith Mohammed Abbas Al-Huseini. M.B.Ch.B., M.Sc, M.Res, Ph.D. Department of Pharmacology and Therapeutics

Tips for Drug Learning. Edward JN Ishac, Ph.D. ANS Review Core Concepts. Neurons of the ANS. Transmitter synthesis and release

Core Safety Profile. Pharmaceutical form(s)/strength: 5mg/ml and 25 mg/ml, Solution for injection, IM/IV FI/H/PSUR/0010/002 Date of FAR:

General anesthesia. No single drug capable of achieving these effects both safely and effectively.

Nervous and chemical regulation heart

למידע נוסף ניתן לעיין בעלון לרופא באתר משרד הבריאות או ליצור קשר טלפוני בטלפון

EVALUATION OF ATRACURIUM BESYLATE AND VECURONIUM BROMIDE IN COMBINATION TO FACILITATE RAPID TRACHEAL INTUBATION

Definition of synapse:

13.01 INHALATIONAL & IV ANAESTHETICS

Anticholinesterases and anticholinergic drugs

Cholinoceptor - Activating &Cholinesterase-Inhibiting Drugs

Comparative study of Succinylcholine, Rocuronium and Vecuronium for intubation and hemodynamic changes during general anaesthesia

Neurology. Brain death. Tests. EEG in Monitoring 3.B.2. Neuromuscular disorders and anaesthesia. Neurology 3.C.6.1 James Mitchell (December 24, 2003)

SOMATIC AND AUTONOMIC UPREGULATION IN THE QUADRIPLEGIC PATIENT

NEUROMUSCULAR BLOCKING AGENTS AND MUSCLE RELAXANTS

Autonomic Nervous System & Neuromuscular Junction Review

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory TRACRIUM. Atracurium Besylate Injection IP

Muscle Tissue. Muscle Tissue Outline. General Function of Muscle Tissue

MUSCLE relaxants are used to provide better operating conditions for

Dr. Hesham Aly Salem Dept. of Pharmacology & Toxicology F O P C U 2016

Cholinergic Agonists & Antagonists

Autonomic Nervous System

Autonomic Nervous System

Lujain Hamdan. Ayman Musleh & Yahya Salem. Mohammed khatatbeh

Hemodynamic effects of muscle relaxants

PAEDIATRIC ANAESTHETIC EMERGENCIES PART I. Dr James Cockcroft, South West School of Anaesthesia. Dr Sarah Rawlinson, Derriford Hospital, Plymouth, UK

Edward JN Ishac, Ph.D. Tips for Drug Learning

NEW ZEALAND DATA SHEET

Comparative study of intubating conditions after Rocuronium and Suxamethonium (study of 80 cases)

PRETREATMENT WITH NON-DEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS AND SUXAMETHONIUM-INDUCED INCREASES IN RESTING JAW TENSION IN CHILDREN

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Transcription:

MUSCLE RELAXANTS Mr. D.Raju, M.pharm, Lecturer

Muscle Relaxants are classified as: I)Peripherally acting A.Neuromuscular blocking agents:- 1) Depolarizing muscle relaxants. 2) Non-depolarizing muscle relaxants B.) Directly acting: Dantrolene, Quinine II)Centrally acting o Chlorzoxazone,Chlormezanone, Diazepam, Baclofen, Tizanidine, Metaxalone.

Depolarizing Muscle relaxants: Succinylcholine (short acting) Non-depolarizing Muscle relaxants: Short acting: Mivacurium Intermediate acting: Atracurium, Cisatracurium, Vecuronium, Rocuronium Long acting : Doxacurium Pancuronium Pipecuronium

MECHANISM OF ACTION SUXAMETHONIUM: Block transmission by causing prolonged depolarization of endplate at neuromuscular junction. Manifestation by initial series of muscle twitches (fasciculation) followed by flaccid paralysis. It immediately metabolize in plasma by Pseudocholinesterase which is synthesized by liver so to prevent its metabolism in plasma it should be given at faster rate.

SYSTEMIC EFFECTS Cardiovascular: Produces muscarinic effects as acetylcholine, therefore causes bradycardia ( but when given high doses causes tachycardia because of stimulation of nicotinic receptors at sympathetic ganglions.) Hyperkalemia: Occurs due to excessive muscle fasciculations. Ventricular fibrillation can occur due to hyperkalemia. CNS: Increases intracranial tension ( due to contraction of neck vessels) Eye: Increases intraocular pressure.

GIT: Increases intra-gastric pressure, salivation, peristalsis. Muscle pains ( myalgia): This is a very common problem in post operative period. These are due to excessive muscle contractions. Malignant hyperthermia Severe Anaphylaxis Masseter Spasm : Sch can cause masseter spasm especially in children & patients susceptible for malignant hyperthermia. Doesnot require reversal rather cholinesterase inhibitors (neostigmine) can prolong the depolarizing block (because these agents also inhibits the pseudocholinesterase)

CONTRAINDICATIONS Hyperkalemia: Serum K > 5.5 is an absolute contraindication for use of Sch. Head Injury : It increase ICP Newborns and infants: These have extrajunctional receptors which are sensitive to depolarizing agents & Sch can produce severe hyperkalemia by interacting with these receptors. Glaucoma & eye injuries. Up to 2-3 months after trauma, Up to 6 months after hemiplegia/paraplegia, Up to 1

Renal Failure : If associated with hyperkalemia. Prolonged intra abdominal infection can be associated with hyperkalemia. Diagnosed case of atypical pseudocholinesterase & low pseudocholinesterase. Duchene muscular dystrophy Dystrophia myotonica: Permanent contractures may develop if SCh is given in these patients. Tetanus. Gullian Barre Syndrome Metabolic Acidosis :Acidosis is associated with hyperkalemia. Shock : It is associated with acidosis which in turn is associated with hyperkalemia. Spinal cord injury.

NON-DEPOLARIZING MUSCLE RELAXANTS: Mechanism of action: It blocks nicotinic receptors competitively resulting in inhibition of sodium channels and excitatory post-synaptic potential. It binds at the same site at which acetylcholine binds. All NDMR are quarternary ammonium compounds & highly water soluble i.e. hydrophilic. So, they do not cross blood brain barrier & placenta except Gallamine.

BROAD CLASSIFICATION These are broadly divided into steroidal compounds and benzylisoquinoline (BZIQ) compunds. STEROIDAL COMPOUNS: (vagolytic properties) It includes PANCURONIUM,VECURONIUM, PIPECURONIUM,ROCURONIUM, RAPACURONIUM. BZIQ(Benzylisoquinoline): (hystamine realease) It includes d-tubocurare, Metocurine, Doxacurium, Atracurium, Mivacurium,

STEROIDAL COMPOUNDS Pancuronium(PAVULON) Very commonly used as it is inexpensive. It releases noradrenaline & can cause tachycardia & hypertension. Because of this there are increased chances of arrhythmia with halothane Pipercuronium It is a pancuronium derivative with no vagolytic activity, so cardiovascular stable, slightly more potent Vercuronium (Norcuron) It is very commonly used now a days. It is cardiovascular stable. Shorter duration of action. It is the muscle relaxant of choice in cardiac patient. Rocuronium 8 times more potent than vecuronium and it also has earlier onset of action Because of onset comparable to succinylcholine it is suitable for rapid sequence intubation as an alternative to succinylcholine.

BENZYLISOQUINOLINE COMPOUNDS D- Tubocurare It is named so because it was carried in bamboo tubes & used as arrow poison for hunting by Amazon people. It has highest propensity to release histamine It causes maximum ganglion blockade. Because of ganglion blocking & histamine releasing property it can produce severe hypotension.

CENTRALLY ACTING MUSCLE RELAXANTS These are drugs which produce muscle relaxation through central mechanism both at supraspinal & spinal level Polysynaptic reflexes involved in maintenance of muscle tone are inhibited at both spinal & supraspinal level. It also produces sedation Uses Muscle spasms. Tetanus : IV diazepam is most effective. Spastic neurological diseases like cerebral

REVERSAL OF BLOCK Drugs used for reversal of block are cholinesterase inhibitors (anticholinesterases). Reversal should be given only after some evidence of spontaneous recovery appear. Mechanism of Action It inactivate the enzyme acetylcholinesterase which is responsible for break down of actetylcholine, thus increasing the amount of acetylcholine available for competition with non depolarizing agent thereby re-establishing neuromuscular transmission. Anticholinesterases used for reversal are: Neostigmine Pyridostigmine Edrophonium Physostigmine

These agents except physostigmine are quarternary ammonium compounds so they do not cross blood brain barrier. The biggest disadvantage is that these agents also increase the acetylcholine level at muscarinic receptors producing muscarinic side effects like bradycardia, bronchospasm. So, to prevent these muscarinic effects some anti cholinergic like atropine or glycopyrrolate is to be given with cholinesterase inhibitors. Neostigmine : Anticholinergic preferred with it is glycopyrrolate because both have same onset of action (both are slow acting). Edrophonium : Anticholinergic preferred with it is atropine (both fast acting). Pyridostigmine: It is preferred drug for renal failure patients in whom a prolonged stay of muscle relaxant is expected.

DRUGS WHICH ANTAGONISE NEUROMUSCULAR BLOCKADE They reverse the block by NDMR only Phenytoin Carbamazepine Calcium Cholinesterase inhibitors Azathioprine Steroids.